152
Participants
Start Date
March 18, 2021
Primary Completion Date
June 23, 2021
Study Completion Date
July 5, 2021
Group A: oropharygeal spray and immunostimulant emulsion
"Intervention 1: Preparation in a liquid solution to be used for oropharyngeal spray, composed of 3 natural bioactive substances of routine use in humans, that feature homologous molecular structures to the native viral receptor.~Intervention 2. Preparation in an emulsion functional food presentation for oral administration, that contains the 8 bioactive compounds that have demonstrated antiviral activity and modulation of the inflammatory response recognized at the moment in the immune activation against the virus."
Group D:Placebo oropharyngeal spray + Placebo taken PO
"Intervention 1: Preparation in a liquid solution to be used for oropharyngeal spray, composed of Placebo substances of routine use in humans.~Intervention 2. Preparation in an emulsion presentation for oral administration that contains the Placebo compounds"
Beatriz Aristizabal, Medellín
Universidad de Antioquia
OTHER
Unidad de Investigación Genética Molecular
NETWORK